Mantle cell lymphoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{ Mantle cell lymphoma }}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Mantle_cell_lymphoma]]
{{CMG}}; {{AE}} {{Akram}} {{AS}}
{{CMG}}; {{AE}} {{Akram}} {{AS}}
==Overview==
==Overview==
Mantle cell lymphoma must be differentiated from other diseases such as [[diffuse large B cell  lymphoma]], [[Mucosa-Associated Lymphatic Tissue lymphoma]] (MALT), [[small cell lymphocytic lymphoma]], and [[follicular lymphoma]].
Mantle cell lymphoma must be differentiated from other diseases that present similarly with [[B symptoms]] ([[Fever|fever,]] [[night sweats]] and unexplained [[weight loss]]), [[lymphocytosis]], [[lymphadenopathy]], [[hepatosplenomegaly]], and [[bone marrow]] involvement.
==Differential Diagnosis==  
==Differential Diagnosis==  
Mantle cell lymphoma must be differentiated from other diseases such as:
Mantle cell lymphoma should be differentiated from other conditions presenting with [[fever]], [[fatigue]], [[lymphadenopathy]], [[abdominal pain]], [[rash]] and [[soft tissue]] [[swelling]]. The differentials include the following:<ref name="pmid18163139">{{cite journal |vauthors=Ejilemele AA, Nwauche CA, Ejele OA |title=Pattern of abnormal liver enzymes in HIV patients presenting at a Nigerian Tertiary Hospital |journal=Niger Postgrad Med J |volume=14 |issue=4 |pages=306–9 |date=December 2007 |pmid=18163139 |doi= |url=}}</ref><ref name="pmid1579936">{{cite journal |vauthors=Gøransson LG, Omdal R, Husby G |title=[Adult-onset Still's disease. Diagnosis, differential diagnosis and treatment] |language=Norwegian |journal=Tidsskr. Nor. Laegeforen. |volume=112 |issue=9 |pages=1155–5 |date=March 1992 |pmid=1579936 |doi= |url=}}</ref><ref name="pmid21734024">{{cite journal |vauthors=Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A |title=Acute hepatitis as a manifestation of parvovirus B19 infection |journal=J. Clin. Microbiol. |volume=49 |issue=9 |pages=3422–4 |date=September 2011 |pmid=21734024 |pmc=3165617 |doi=10.1128/JCM.00575-11 |url=}}</ref><ref name="pmid25780346">{{cite journal |vauthors=Yaguchi D, Marui N, Matsuo M |title=Three Adult Cases of HPV-B19 Infection with Concomitant Leukopenia and Low Platelet Counts |journal=Clin Med Insights Case Rep |volume=8 |issue= |pages=19–22 |date=2015 |pmid=25780346 |pmc=4345940 |doi=10.4137/CCRep.S18085 |url=}}</ref><ref name="pmid11810534">{{cite journal |vauthors=Díaz F, Collazos J |title=Hepatic dysfunction due to parvovirus B19 infection |journal=J. Infect. Chemother. |volume=6 |issue=1 |pages=63–4 |date=March 2000 |pmid=11810534 |doi=10.1007/s101560000023 |url=}}</ref><ref name="urlwatermark.silverchair.com">{{cite web |url=https://watermark.silverchair.com/22-5-783.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAaUwggGhBgkqhkiG9w0BBwagggGSMIIBjgIBADCCAYcGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMNepsAzlRiawaxgMCAgEQgIIBWCcwAN4r_jjoL6cD8qOBCgCIgpagHIemSBzmiP_c08L34mY51H7ulShPj9n2yDVBVRols0OgZEIsKVl8kHD_89enHvhFrJOIh8cF7GxZ_AXULME_iReJXr37VWLU5bWFrtZHafAg_cvOdP8mr5u5K8TzGLBtd5VfQb2MGyXZhz-hpKGZbfMr33rJio00VHcFn_aS5wjB-h6fny_rsD4fwLj5xSWNB0_JEYq9g0-mS7y_igwhIZlismSrS4-svrkx46SDLpKqkTrJmImyDBGTj1Qi3INV8KT66j4j6z2wju7sRKvWxQAsoJhN6D8zxx5PQkth3gLDch3wLW_sn9o8q7sBlO25ONobKarrln8nwsS4f-9wHmPs82ZySggX4SgVtrMn6tr3lMVcroGV9fjOIcQQuk_KRq01ErxBdPtynPVbAZhmInGIJ0_LYqvOKplDpNnMHZZaEQYd |title=watermark.silverchair.com |format= |work= |accessdate=}}</ref><ref name="pmid23355575">{{cite journal |vauthors=Shetty RK, Vivek G, Naha K, Bekkam S |title=Right-sided infective endocarditis presenting with purpuric skin rash and cardiac failure in a patient without fever |journal=BMJ Case Rep |volume=2013 |issue= |pages= |date=January 2013 |pmid=23355575 |pmc=3603787 |doi=10.1136/bcr-2012-007841 |url=}}</ref><ref name="pmid23133445">{{cite journal |vauthors=Aucott JN, Crowder LA, Yedlin V, Kortte KB |title=Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans |journal=Dermatol Res Pract |volume=2012 |issue= |pages=451727 |date=2012 |pmid=23133445 |pmc=3485866 |doi=10.1155/2012/451727 |url=}}</ref><ref name="pmid21772606">{{cite journal |vauthors=Karaali Z, Baysal B, Poturoglu S, Kendir M |title=Cutaneous manifestations in brucellosis |journal=Indian J Dermatol |volume=56 |issue=3 |pages=339–40 |date=May 2011 |pmid=21772606 |pmc=3132922 |doi=10.4103/0019-5154.82505 |url=}}</ref><ref name="pmid18843212">{{cite journal |vauthors=La Spada E, Micalizzi A, La Spada M, Quartarano P, Nugara G, Soresi M, Affronti M, Montalto G |title=[Abnormal liver function in brucellosis] |language=Italian |journal=Infez Med |volume=16 |issue=3 |pages=148–53 |date=September 2008 |pmid=18843212 |doi= |url=}}</ref><ref name="pmid17235095">{{cite journal |vauthors=French P |title=Syphilis |journal=BMJ |volume=334 |issue=7585 |pages=143–7 |date=January 2007 |pmid=17235095 |pmc=1779891 |doi=10.1136/bmj.39085.518148.BE |url=}}</ref><ref name="urlSyphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features">{{cite web |url=http://cmr.asm.org/content/12/2/187.full |title=Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features |format= |work= |accessdate=}}</ref><ref name="pmid24700957">{{cite journal |vauthors=Baveja S, Garg S, Rajdeo A |title=Syphilitic hepatitis: an uncommon manifestation of a common disease |journal=Indian J Dermatol |volume=59 |issue=2 |pages=209 |date=March 2014 |pmid=24700957 |pmc=3969699 |doi=10.4103/0019-5154.127711 |url=}}</ref><ref name="pmid1600010">{{cite journal |vauthors=Mawhorter SD, Effron D, Blinkhorn R, Spagnuolo PJ |title=Cutaneous manifestations of toxoplasmosis |journal=Clin. Infect. Dis. |volume=14 |issue=5 |pages=1084–8 |date=May 1992 |pmid=1600010 |doi= |url=}}</ref><ref name="pmid24662942">{{cite journal |vauthors=Flegr J, Prandota J, Sovičková M, Israili ZH |title=Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries |journal=PLoS ONE |volume=9 |issue=3 |pages=e90203 |date=2014 |pmid=24662942 |pmc=3963851 |doi=10.1371/journal.pone.0090203 |url=}}</ref><ref name="pmid21887062">{{cite journal |vauthors=Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL |title=Toxoplasmosis: a global threat |journal=J Glob Infect Dis |volume=3 |issue=3 |pages=281–4 |date=July 2011 |pmid=21887062 |pmc=3162817 |doi=10.4103/0974-777X.83536 |url=}}</ref><ref name="pmid10808314">{{cite journal |vauthors=Ripert C |title=[Reactive hypereosinophilia in parasitic diseases] |language=French |journal=Rev Prat |volume=50 |issue=6 |pages=602–7 |date=March 2000 |pmid=10808314 |doi= |url=}}</ref><ref name="pmid21569516">{{cite journal |vauthors=Alvarado-Esquivel C, Torres-Berumen JL, Estrada-Martínez S, Liesenfeld O, Mercado-Suarez MF |title=Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population |journal=Parasit Vectors |volume=4 |issue= |pages=75 |date=May 2011 |pmid=21569516 |pmc=3105944 |doi=10.1186/1756-3305-4-75 |url=}}</ref><ref name="pmid5339237">{{cite journal |vauthors=Han T, Stutzman L |title=Mode of spread in patients with localized malignant lymphoma |journal=Arch. Intern. Med. |volume=120 |issue=1 |pages=1–7 |date=July 1967 |pmid=5339237 |doi= |url=}}</ref><ref name="pmid23071471">{{cite journal |vauthors=Saeed-Abdul-Rahman I, Al-Amri AM |title=Castleman disease |journal=Korean J Hematol |volume=47 |issue=3 |pages=163–77 |date=September 2012 |pmid=23071471 |pmc=3464333 |doi=10.5045/kjh.2012.47.3.163 |url=}}</ref><ref name="pmid230714712">{{cite journal |vauthors=Saeed-Abdul-Rahman I, Al-Amri AM |title=Castleman disease |journal=Korean J Hematol |volume=47 |issue=3 |pages=163–77 |date=September 2012 |pmid=23071471 |pmc=3464333 |doi=10.5045/kjh.2012.47.3.163 |url=}}</ref><ref name="pmid21063526">{{cite journal |vauthors=Papadavid E, Panayiotides I, Dalamaga M, Katoulis A, Economopoulos T, Stavrianeas N |title=Cutaneous involvement in angioimmunoblastic T-cell lymphoma |journal=Indian J Dermatol |volume=55 |issue=3 |pages=279–80 |date=2010 |pmid=21063526 |pmc=2965920 |doi=10.4103/0019-5154.70704 |url=}}</ref><ref name="pmid26120552">{{cite journal |vauthors=Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF |title=Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM) |journal=Allergo J Int |volume=24 |issue=3 |pages=94–105 |date=2015 |pmid=26120552 |pmc=4479479 |doi=10.1007/s40629-015-0052-6 |url=}}</ref><ref name="pmid15745878">{{cite journal |vauthors=Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A |title=[Familial Mediterranean Fever (FMF): from diagnosis to treatment] |language=French |journal=Sante |volume=14 |issue=4 |pages=261–6 |date=2004 |pmid=15745878 |doi= |url=}}</ref><ref name="pmid27142780">{{cite journal |vauthors=Zhang S |title=Natural history of mevalonate kinase deficiency: a literature review |journal=Pediatr Rheumatol Online J |volume=14 |issue=1 |pages=30 |date=May 2016 |pmid=27142780 |pmc=4855321 |doi=10.1186/s12969-016-0091-7 |url=}}</ref>
 
{| class="wikitable"
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Category of Disease
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! colspan="10" align="center" style="background:#4479BA; color: #FFFFFF;" + |Signs and symptoms
! colspan="11" align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory findings
|-
| rowspan="2" |'''Fever'''
| rowspan="2" |'''Fatigue'''
| rowspan="2" |'''Arthralgia'''
| rowspan="2" |'''Myalgia'''
| rowspan="2" |'''Soft tissue swelling/serositis'''
| rowspan="2" |'''Skin rash'''
| rowspan="2" |'''Weight loss'''
| rowspan="2" |'''Dyspnea'''
| rowspan="2" |'''Sore throat'''
| rowspan="2" |'''Lymphadenopathy'''
| rowspan="2" |'''Complete blood count (CBC)'''
| rowspan="2" |'''Liver function tests (LFTs)'''
| colspan="2" |
=== Inflammatory markers ===
| colspan="6" |
=== Autoantibodies ===
|
=== Diagnostic tests ===
|-
|'''Erythrocyte sedimentation rate (ESR)'''
|'''C- reactive protein (CRP)'''
|'''Anti-nuclear antibodies (ANA)'''
|'''Rheumatoid factor (RF)'''
|'''Anti- glomerular basement membrane (anti-GBM)'''
|'''Anti-dsDNA'''
|'''Anti-Jo1/ Anti Mi2'''
|'''ANCA'''
|
|-
| rowspan="9" |
=== Infections ===
| [[Human Immunodeficiency Virus (HIV)|'''HIV''']]
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+ /-</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukopenia]]
* [[Anemia]]
* [[Thrombocytopenia]]
|
* [[Alanine transaminase|ALT]]'''↑'''
* [[Aspartate transaminase|AST]]'''↑'''
|'''↑'''
|'''↑'''
| -
| -
| -
| -
| -
| -
|
|-
| ''[[Herpesviridae|'''Herpesviridae''']]''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* Papular or vesicular
* [[Erythematous]] base
* Painful
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|
|-
| '''[[Measles]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|
* 3-5 days after fever
* [[Erythematous]] [[maculopapular]] rash starts on face spreads to trunk and [[extremities]] (centrifugal)
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|
|-
| '''[[Hepatitis|Viral hepatitis]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|
* [[Leukocytosis]]
|
* [[Alanine transaminase|ALT]]'''↑'''
* [[Aspartate transaminase|AST]]'''↑'''
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|
|-
| ''[[Parvovirus B19|'''Parvovirus B19''']]''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|
* Slapped cheek rash
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukopenia]]
* [[Aplastic anemia]] (low [[reticulocyte]] count)
* [[Thrombocytopenia]]
|
* [[Alanine transaminase|ALT]]'''↑'''
* [[Aspartate transaminase|AST]]'''↑'''
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|
|-
|'''[[Infective endocarditis]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|
* [[Purpuric]]
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Blood cultures, ultrasonography
|-
|'''[[Borreliosis]], [[Brucellosis]], [[Yersiniosis]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|
* Target rash ([[Borrelia]])
* Diffuse [[maculopapular]] ([[Brucellosis]])
* [[Erythema nodosum]] ([[Yersiniosis]])
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]]
|
* [[Alanine transaminase|ALT]]'''↑'''
* [[Aspartate transaminase|AST]]'''↑'''
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Serology, PCR
|-
|'''[[Syphilis]] and [[Jarisch-Herxheimer reaction]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|
* Non-pruritic
* [[Macular]]
* On palms and soles
* Round
* Seen in [[secondary syphilis]]
* [[Penis|Penile]] [[ulceration]] (painless)
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]]
|
* [[Alanine transaminase|ALT]]'''↑''' (Uncommon)
* [[Aspartate transaminase|AST]]'''↑''' (Uncommon)
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Serology, PCR
|-
|'''[[Toxoplasmosis]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|
* [[Maculopapular]]
* Palms and soles
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]] (eosinophilia)
|
|
|
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Serology, PCR
|-
|
| colspan="22" |
|-
| rowspan="3" |
=== Neoplasia ===
|'''[[Malignant lymphoma]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|
* Purplish scaly rash in cases of [[cutaneous]] [[lymphoma]]
|<nowiki>+</nowiki>
|<nowiki>+ </nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Anemia of chronic disease]]
|
* In case of [[liver]] [[metastasis]] ([[Non-Hodgkin lymphoma]]):
** [[Alanine transaminase|ALT]]'''↑'''
** [[Aspartate transaminase|AST]]'''↑'''
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|CT, PET/CT, Bone marrow examination, lymph node biopsy
|-
|'''[[Castleman's disease|Multicentric Castleman disease]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Anemia]]
* [[Thrombocytopenia]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Lymph node biopsy
|-
|'''[[Angioimmunoblastic T-cell lymphoma|Angioimmunoblastic T cell lymphoma]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
* [[Maculopapular]] eruption on the trunk mimicking [[Erythema toxicum|toxic erythema]]
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Lymphocytosis]]
|
* [[Alanine transaminase|ALT]]'''↑'''
* [[Aspartate transaminase|AST]]'''↑'''
|'''↑'''
|↑
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Lymph node biopsy
|-
|
| colspan="22" |
|-
|
=== Drug hypersensitivity ===
|Drug reaction with eosinophilia and systemic symptoms
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|
* [[Urticaria|Utricaria]] (Immediate type)
* [[Maculopapular]] (Delayed type)
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
* [[Leukocytosis]] ([[eosinophilia]])
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Eosinophil count, skin biopsy
|-
|
| colspan="22" |
|-
| rowspan="7" |Autoimmune conditions
|'''[[Systemic lupus erythematosus]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|
* Butter-fly shaped [[erythematous]] malar rash that spares the [[nasolabial folds]]
* Coin-shaped [[erythematous]] rash on extremities or trunk
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|
* [[Leukopenia]]
* [[Hemolytic anemia]]
* [[Thrombocytopenia]]
|
* [[ALT]]'''↑'''
* [[AST]]'''↑'''
|'''↑'''
|'''↑'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
| -
| -
|Antinuclear autoantibodies
|-
|'''Inflammatory myositis'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+ (weakness > pain)</nowiki>
|<nowiki>-</nowiki>
|
* [[Macular]] red rash over the back of the fingers, elbows or knees (Grotton's sign)
* [[Macular]] purpish or reddish rash on the upper chest or back  (Shawl-like, heliotrope rash)
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|
* [[Leukocytosis]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| -
|Idem, muscle biopsy
|-
|[[Rheumatoid arthritis|'''Rheumatoid arthritis''']]
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Purpura]]
* [[Ulcers]]
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Anemia of chronic disease]]
* [[Neutropenia]] ([[Felty's syndrome]])
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| -
| -
|Anti-citrullinated peptids autoantibodies, rheumatoid factor
|-
|'''[[Systemic vasculitides]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* Nasopharyngeal ulceration ([[Wegener's granulomatosis|Wegner's granulomatosis]])
* [[Erythematous]] rash on palms and soles ([[Kawasaki disease]])
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|
* [[Leukocytosis]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
| -
| +
|ANCA, tissue biopsy, arteriography
|-
|'''[[Familial mediterranean fever|Familial Mediterranean fever]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* Red rash on [[lower extremities]] (ankles and knees)
|<nowiki>+</nowiki>
|<nowiki>+ (due to pain)</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|
* [[Leukocytosis]] (during acute flares)
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|Familial history, MEFV gene analysis
|-
|'''[[Mevalonate kinase deficiency]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|
* [[Maculopapular]] rash
* [[Aphthous ulcers]] (or [[stomatitis]]) 
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]] (during acute flares)
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|Urinary mevalonic acid, mevalonate kinase analysis
|-
|'''[[Reactive arthritis]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
* [[Keratoderma blennorrhagica]] (palms, soles, scrotum)
* Circinate balanitis (penile)
|<nowiki>-</nowiki>
| + ([[Aortic insufficiency]])
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Leukocytosis]]
|<nowiki>-</nowiki>
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|HLA B27, magnetic resonance imaging
|-
|
| colspan="22" |
|-
| rowspan="3" |
=== Miscellaneous ===
|'''[[Sarcoidosis]]'''
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* Waxy skin [[plaques]]
* Violaceous facial lesions
* [[Erythema nodosum]]
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|
* [[Lymphopenia]]
* [[Eosinophilia]]
|
* Normal [[Alanine transaminase|ALT]], [[Aspartate transaminase|AST]]
* [[Alkaline phosphatase|ALP]] '''↑ (infiltrative pattern)'''
|'''↑'''
|'''↑'''
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
* Lymph node/Lung biopsy
* ACE levels
* FDG-PET
|-
|'''Neutrophilic dermatosis'''
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[Kikuchi-Fujimoto disease|'''Kikuchi–Fujimoto disease''']]
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|}
Mantle cell lymphoma must be differentiated from other diseases such as:<ref>{{Cite journal
| author = [[Elias Campo]], [[Steven H. Swerdlow]], [[Nancy L. Harris]], [[Stefano Pileri]], [[Harald Stein]] & [[Elaine S. Jaffe]]
| title = The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
| journal = [[Blood]]
| volume = 117
| issue = 19
| pages = 5019–5032
| year = 2011
| month = May
| doi = 10.1182/blood-2011-01-293050
| pmid = 21300984
}}</ref><ref>{{Cite journal
| author = [[Alejandra Carvajal-Cuenca]], [[Luz F. Sua]], [[Nhora M. Silva]], [[Stefania Pittaluga]], [[Cristina Royo]], [[Joo Y. Song]], [[Rachel L. Sargent]], [[Blanca Espinet]], [[Fina Climent]], [[Samuel A. Jacobs]], [[Jan Delabie]], [[Kikkeri N. Naresh]], [[Adam Bagg]], [[Pierre Brousset]], [[Roger A. Warnke]], [[Sergi Serrano]], [[Nancy Lee Harris]], [[Steven H. Swerdlow]], [[Elaine S. Jaffe]] & [[Elias Campo]]
| title = In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
| journal = [[Haematologica]]
| volume = 97
| issue = 2
| pages = 270–278
| year = 2012
| month = February
| doi = 10.3324/haematol.2011.052621
| pmid = 22058203
}}</ref><ref>{{Cite journal
| author = [[Gabor Barna]], [[Lilla Reiniger]], [[Peter Tatrai]], [[Laszlo Kopper]] & [[Andras Matolcsy]]
| title = The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL
| journal = [[Hematological oncology]]
| volume = 26
| issue = 3
| pages = 167–170
| year = 2008
| month = September
| doi = 10.1002/hon.855
| pmid = 18381689
}}</ref>
 
===Differentials Based on Cell Markers===
Based on the expression of cell surface markers, the table below differentiates mantle cell lymphoma from other diseases that cause similar clinical presentations:<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>
<br>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
| valign="top" |
|+
! style="background: #4479BA; width: 600px;" | {{fontcolor|#FFF|'''Differential Diagnosis'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''Surface Immunoglobulin'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD5'''}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''CD22/FMC7'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD23'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD79b'''}}
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|'''CD103'''}}
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Chronic lymphocytic leukemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Weakly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive/Negative'''
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''[[Prolymphocytic leukemia]]'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''[[Hairy cell leukemia]]'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive/Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''[[Mantle cell lymphoma]]'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''[[Follicular lymphoma]]'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |
'''Negative'''
|}
 
===Other Differentials===
*[[Diffuse large B cell  lymphoma]]
*[[Diffuse large B cell  lymphoma]]
*[[Mucosa-Associated Lymphatic Tissue lymphoma]] (MALT)
*[[Mucosa-Associated Lymphatic Tissue lymphoma]] (MALT)
*[[Small cell lymphocytic lymphoma]]
*[[Follicular lymphoma]]
*[[Follicular lymphoma]]
*[[Small lymphocytic lymphoma]] / [[Chronic lymphocytic leukemia]]
*Lymphoplasmacytoid lymphoma / Immunocytoma
*[[Marginal zone lymphoma]]
*[[Lymphoblastic lymphoma]]
*[[Burkitt lymphoma]]
*Reactive hyperplasia


==References==
==References==

Latest revision as of 21:44, 28 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]

Overview

Mantle cell lymphoma must be differentiated from other diseases that present similarly with B symptoms (fever, night sweats and unexplained weight loss), lymphocytosis, lymphadenopathy, hepatosplenomegaly, and bone marrow involvement.

Differential Diagnosis

Mantle cell lymphoma should be differentiated from other conditions presenting with fever, fatigue, lymphadenopathy, abdominal pain, rash and soft tissue swelling. The differentials include the following:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25]

Category of Disease Diseases Signs and symptoms Laboratory findings
Fever Fatigue Arthralgia Myalgia Soft tissue swelling/serositis Skin rash Weight loss Dyspnea Sore throat Lymphadenopathy Complete blood count (CBC) Liver function tests (LFTs)

Inflammatory markers

Autoantibodies

Diagnostic tests

Erythrocyte sedimentation rate (ESR) C- reactive protein (CRP) Anti-nuclear antibodies (ANA) Rheumatoid factor (RF) Anti- glomerular basement membrane (anti-GBM) Anti-dsDNA Anti-Jo1/ Anti Mi2 ANCA

Infections

  HIV + + + + +/- - + +/- + /- + ↑ ↑ - - - - - -
 Herpesviridae + + + + + - - +/- + - ↑ ↑ - - - - - -
 Measles + + + + - - - + + - ↑ ↑ - - - - - -
 Viral hepatitis + + - +/- - - +/- - - +/- ↑ ↑ - - - - - -
 Parvovirus B19 + + + +/- -
  • Slapped cheek rash
 - - - + ↑ ↑ - - - - - -
Infective endocarditis + + + +/- - +/- + - + - ↑ ↑ - - - - - - Blood cultures, ultrasonography
Borreliosis, Brucellosis, Yersiniosis + + + + - - - - + ↑ ↑ - - - - - - Serology, PCR
Syphilis and Jarisch-Herxheimer reaction + + + + - - - + +
  • ALT↑ (Uncommon)
  • AST↑ (Uncommon)
 ↑ ↑ - - - - - - Serology, PCR
Toxoplasmosis + + - + - - - + + - - - - - - Serology, PCR

Neoplasia

 Malignant lymphoma + + - +/- +/- + + - + ↑ ↑ - - - - - - CT, PET/CT, Bone marrow examination, lymph node biopsy
Multicentric Castleman disease + + - - + - + + - + - ↑ ↑ - - - - - - Lymph node biopsy
Angioimmunoblastic T cell lymphoma + + - - - + - - + ↑ ↑ - - - - - - Lymph node biopsy

Drug hypersensitivity

 Drug reaction with eosinophilia and systemic symptoms + + + + +/- - + - - - ↑ ↑ - - - - - - Eosinophil count, skin biopsy
Autoimmune conditions Systemic lupus erythematosus + + + +/- + + + - +/- ↑ ↑ + + - + - - Antinuclear autoantibodies
Inflammatory myositis + + - + (weakness > pain) -
  • Macular red rash over the back of the fingers, elbows or knees (Grotton's sign)
  • Macular purpish or reddish rash on the upper chest or back  (Shawl-like, heliotrope rash)
 - - - +/- - ↑ ↑ +/- +/- - - + - Idem, muscle biopsy
Rheumatoid arthritis + + + - + - + - + - ↑ ↑ +/- +/- - - - - Anti-citrullinated peptids autoantibodies, rheumatoid factor
Systemic vasculitides + + + - + - +/- - +/- - ↑ ↑ - - +/- - - + ANCA, tissue biopsy, arteriography
Familial Mediterranean fever + + + + + + + (due to pain) - +/- - ↑ ↑ - - - - - - Familial history, MEFV gene analysis
Mevalonate kinase deficiency + + + + - + - + + - ↑ ↑ - - - - - - Urinary mevalonic acid, mevalonate kinase analysis
Reactive arthritis + + + - - - + (Aortic insufficiency) - + - ↑ ↑ - - - - - - HLA B27, magnetic resonance imaging

Miscellaneous

 Sarcoidosis + + + - + + + - +
  • Normal ALT, AST
  • ALP ↑ (infiltrative pattern)
 ↑ ↑ - - - - - -
  • Lymph node/Lung biopsy
  • ACE levels
  • FDG-PET
Neutrophilic dermatosis
Kikuchi–Fujimoto disease

Mantle cell lymphoma must be differentiated from other diseases such as:[26][27][28]

Differentials Based on Cell Markers

Based on the expression of cell surface markers, the table below differentiates mantle cell lymphoma from other diseases that cause similar clinical presentations:[29]

Differential Diagnosis Surface Immunoglobulin CD5 CD22/FMC7 CD23 CD79b CD103

Chronic lymphocytic leukemia

Weakly positive

Positive

Negative

Positive

Negative

Positive/Negative

Prolymphocytic leukemia

Strongly positive

Negative

Positive

Negative

Positive

Negative

Hairy cell leukemia

Strongly positive

Negative

Positive

Negative

Positive/Negative

Positive

Mantle cell lymphoma

Positive

Positive

Strongly positive

Negative

Strongly positive

Negative

Follicular lymphoma

Strongly positive

Negative

Positive

Negative

Strongly positive

Negative

Other Differentials

References

  1. ↑ Ejilemele AA, Nwauche CA, Ejele OA (December 2007). "Pattern of abnormal liver enzymes in HIV patients presenting at a Nigerian Tertiary Hospital". Niger Postgrad Med J. 14 (4): 306–9. PMID 18163139.
  2. ↑ Gøransson LG, Omdal R, Husby G (March 1992). "[Adult-onset Still's disease. Diagnosis, differential diagnosis and treatment]". Tidsskr. Nor. Laegeforen. (in Norwegian). 112 (9): 1155–5. PMID 1579936.
  3. ↑ Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A (September 2011). "Acute hepatitis as a manifestation of parvovirus B19 infection". J. Clin. Microbiol. 49 (9): 3422–4. doi:10.1128/JCM.00575-11. PMC 3165617. PMID 21734024.
  4. ↑ Yaguchi D, Marui N, Matsuo M (2015). "Three Adult Cases of HPV-B19 Infection with Concomitant Leukopenia and Low Platelet Counts". Clin Med Insights Case Rep. 8: 19–22. doi:10.4137/CCRep.S18085. PMC 4345940. PMID 25780346.
  5. ↑ Díaz F, Collazos J (March 2000). "Hepatic dysfunction due to parvovirus B19 infection". J. Infect. Chemother. 6 (1): 63–4. doi:10.1007/s101560000023. PMID 11810534.
  6. ↑ "watermark.silverchair.com" (PDF).
  7. ↑ Shetty RK, Vivek G, Naha K, Bekkam S (January 2013). "Right-sided infective endocarditis presenting with purpuric skin rash and cardiac failure in a patient without fever". BMJ Case Rep. 2013. doi:10.1136/bcr-2012-007841. PMC 3603787. PMID 23355575.
  8. ↑ Aucott JN, Crowder LA, Yedlin V, Kortte KB (2012). "Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans". Dermatol Res Pract. 2012: 451727. doi:10.1155/2012/451727. PMC 3485866. PMID 23133445.
  9. ↑ Karaali Z, Baysal B, Poturoglu S, Kendir M (May 2011). "Cutaneous manifestations in brucellosis". Indian J Dermatol. 56 (3): 339–40. doi:10.4103/0019-5154.82505. PMC 3132922. PMID 21772606.
  10. ↑ La Spada E, Micalizzi A, La Spada M, Quartarano P, Nugara G, Soresi M, Affronti M, Montalto G (September 2008). "[Abnormal liver function in brucellosis]". Infez Med (in Italian). 16 (3): 148–53. PMID 18843212.
  11. ↑ French P (January 2007). "Syphilis". BMJ. 334 (7585): 143–7. doi:10.1136/bmj.39085.518148.BE. PMC 1779891. PMID 17235095.
  12. ↑ "Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features".
  13. ↑ Baveja S, Garg S, Rajdeo A (March 2014). "Syphilitic hepatitis: an uncommon manifestation of a common disease". Indian J Dermatol. 59 (2): 209. doi:10.4103/0019-5154.127711. PMC 3969699. PMID 24700957.
  14. ↑ Mawhorter SD, Effron D, Blinkhorn R, Spagnuolo PJ (May 1992). "Cutaneous manifestations of toxoplasmosis". Clin. Infect. Dis. 14 (5): 1084–8. PMID 1600010.
  15. ↑ Flegr J, Prandota J, Sovičková M, Israili ZH (2014). "Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries". PLoS ONE. 9 (3): e90203. doi:10.1371/journal.pone.0090203. PMC 3963851. PMID 24662942.
  16. ↑ Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL (July 2011). "Toxoplasmosis: a global threat". J Glob Infect Dis. 3 (3): 281–4. doi:10.4103/0974-777X.83536. PMC 3162817. PMID 21887062.
  17. ↑ Ripert C (March 2000). "[Reactive hypereosinophilia in parasitic diseases]". Rev Prat (in French). 50 (6): 602–7. PMID 10808314.
  18. ↑ Alvarado-Esquivel C, Torres-Berumen JL, Estrada-Martínez S, Liesenfeld O, Mercado-Suarez MF (May 2011). "Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population". Parasit Vectors. 4: 75. doi:10.1186/1756-3305-4-75. PMC 3105944. PMID 21569516.
  19. ↑ Han T, Stutzman L (July 1967). "Mode of spread in patients with localized malignant lymphoma". Arch. Intern. Med. 120 (1): 1–7. PMID 5339237.
  20. ↑ Saeed-Abdul-Rahman I, Al-Amri AM (September 2012). "Castleman disease". Korean J Hematol. 47 (3): 163–77. doi:10.5045/kjh.2012.47.3.163. PMC 3464333. PMID 23071471.
  21. ↑ Saeed-Abdul-Rahman I, Al-Amri AM (September 2012). "Castleman disease". Korean J Hematol. 47 (3): 163–77. doi:10.5045/kjh.2012.47.3.163. PMC 3464333. PMID 23071471.
  22. ↑ Papadavid E, Panayiotides I, Dalamaga M, Katoulis A, Economopoulos T, Stavrianeas N (2010). "Cutaneous involvement in angioimmunoblastic T-cell lymphoma". Indian J Dermatol. 55 (3): 279–80. doi:10.4103/0019-5154.70704. PMC 2965920. PMID 21063526.
  23. ↑ Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, Fuchs T, Jakob T, Lange L, Pfützner W, Mockenhaupt M, Ott H, Pfaar O, Ring J, Sachs B, Sitter H, Trautmann A, Treudler R, Wedi B, Worm M, Wurpts G, Zuberbier T, Merk HF (2015). "Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM)". Allergo J Int. 24 (3): 94–105. doi:10.1007/s40629-015-0052-6. PMC 4479479. PMID 26120552.
  24. ↑ Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A (2004). "[Familial Mediterranean Fever (FMF): from diagnosis to treatment]". Sante (in French). 14 (4): 261–6. PMID 15745878.
  25. ↑ Zhang S (May 2016). "Natural history of mevalonate kinase deficiency: a literature review". Pediatr Rheumatol Online J. 14 (1): 30. doi:10.1186/s12969-016-0091-7. PMC 4855321. PMID 27142780.
  26. ↑ Elias Campo, Steven H. Swerdlow, Nancy L. Harris, Stefano Pileri, Harald Stein & Elaine S. Jaffe (2011). "The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications". Blood. 117 (19): 5019–5032. doi:10.1182/blood-2011-01-293050. PMID 21300984. Unknown parameter |month= ignored (help)
  27. ↑ Alejandra Carvajal-Cuenca, Luz F. Sua, Nhora M. Silva, Stefania Pittaluga, Cristina Royo, Joo Y. Song, Rachel L. Sargent, Blanca Espinet, Fina Climent, Samuel A. Jacobs, Jan Delabie, Kikkeri N. Naresh, Adam Bagg, Pierre Brousset, Roger A. Warnke, Sergi Serrano, Nancy Lee Harris, Steven H. Swerdlow, Elaine S. Jaffe & Elias Campo (2012). "In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior". Haematologica. 97 (2): 270–278. doi:10.3324/haematol.2011.052621. PMID 22058203. Unknown parameter |month= ignored (help)
  28. ↑ Gabor Barna, Lilla Reiniger, Peter Tatrai, Laszlo Kopper & Andras Matolcsy (2008). "The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL". Hematological oncology. 26 (3): 167–170. doi:10.1002/hon.855. PMID 18381689. Unknown parameter |month= ignored (help)
  29. ↑ Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011

Template:Hematology

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Mantle_cell_lymphoma_differential_diagnosis&oldid=1555297"